China Resources Double-Crane Stock Hits Day Low Amid Price Pressure at CNY 16.90

China Resources Double-Crane Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.26% on July 17, 2026. The stock reached an intraday low of CNY 16.90, reflecting a challenging trading environment. In terms of performance metrics, the company has shown a mixed trajectory over various time frames. Over the past year, the stock has generated a return of -11.82%, significantly underperforming the China Shanghai Composite, which has gained 7.03% during the same period. Year-to-date, the stock is down 7.44%, compared to the composite's decline of 5.16%. Despite a five-year performance increase of 48.51%, the company has faced headwinds in recent times, with net sales growing at an annual rate of 5.57% and operating profit at 6.99%. The return on equity stands at 14.83%, and the stock currently offers a dividend yield of 2.85%. Overall, China Resources Double-Crane Pharmaceutical Co., Ltd. is navigating a complex market landscape, marked by both short-term volatility and long-term growth challenges.